WallStreetZenWallStreetZen

NASDAQ: OVID
Ovid Therapeutics Inc Stock Ownership - Who owns Ovid Therapeutics?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Ovid Therapeutics Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Jeremy M. LevinCEO2024-03-1818,248$2.76
$50.36kBuy

1 of 1

OVID insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when OVID insiders and whales buy or sell their stock.

OVID Shareholders

What type of owners hold Ovid Therapeutics Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Takeda Pharmaceutical Co Ltd10.65%7,531,996$23.05MInsider
Bvf Inc9.69%6,851,051$20.96MInstitution
Ecor1 Capital LLC8.65%6,117,400$18.72MInstitution
Rubric Capital Management LP7.52%5,315,969$16.27MInstitution
Matthew During6.75%4,772,429$14.60MInsider
Blackrock Inc6.11%4,319,918$13.22MInstitution
Jeremy M. Levin5.17%3,652,176$11.18MInsider
Madison Avenue Partners LP5.16%3,648,509$11.16MInstitution
Vanguard Group Inc4.23%2,989,777$9.15MInstitution
Artal Group Sa3.54%2,500,000$7.65MInstitution

1 of 3

OVID vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
OVID62.41%23.75%Net BuyingNet Buying
MACK23.49%76.51%Net Buying
OMER43.03%6.69%Net Buying
PRLD52.43%47.57%Net BuyingNet Selling
FBLG0.00%0.39%
View Top Biotech Stocks

Ovid Therapeutics Stock Ownership FAQ

Who owns Ovid Therapeutics?

Ovid Therapeutics (NASDAQ: OVID) is owned by 62.41% institutional shareholders, 23.75% Ovid Therapeutics insiders, and 13.85% retail investors. Takeda Pharmaceutical Co Ltd is the largest individual Ovid Therapeutics shareholder, owning 7.53M shares representing 10.65% of the company. Takeda Pharmaceutical Co Ltd's Ovid Therapeutics shares are currently valued at $23.12M.

If you're new to stock investing, here's how to buy Ovid Therapeutics stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.